We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$17.7B
AUM Growth
+$1.64B
Cap. Flow
+$829M
Cap. Flow %
4.68%
Top 10 Hldgs %
32.88%
Holding
1,375
New
60
Increased
737
Reduced
285
Closed
62

Top Buys

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$115M
2
ESS icon
Essex Property Trust
ESS
+$110M
3
AAPL icon
Apple
AAPL
+$103M
4
TSLA icon
Tesla
TSLA
+$101M
5
MSFT icon
Microsoft
MSFT
+$97.5M

Sector Composition

Rank Sector Weight
1 Real Estate 45.88%
2 Technology 16.72%
3 Consumer Discretionary 5.58%
4 Communication Services 5.5%
5 Financials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRYS icon
1126
Krystal Biotech
KRYS
$10.7B
$19K ﹤0.01%
105
-10
-9% -$1.39K
CLPR
1127
Clipper Realty
CLPR
$46.4M
$18K ﹤0.01%
3,778
OUT icon
1128
Outfront Media
OUT
$5.75B
$18K ﹤0.01%
1,070
IMVT icon
1129
Immunovant
IMVT
$7.93B
$17K ﹤0.01%
537
-55
-9% -$2.01K
NUVL
1130
DELISTED
Nuvalent
NUVL
$16K ﹤0.01%
217
-17
-7% -$1.35K
VUZI icon
1131
Vuzix
VUZI
$178M
$16K ﹤0.01%
13,579
-887
-6% -$1.45K
IBRX icon
1132
ImmunityBio
IBRX
$7.15B
$15K ﹤0.01%
2,730
INSM icon
1133
Insmed
INSM
$22.4B
$15K ﹤0.01%
545
IOVA icon
1134
Iovance Biotherapeutics
IOVA
$2.04B
$15K ﹤0.01%
1,032
+155
+18% +$1.8K
OGE icon
1135
OGE Energy
OGE
$9.86B
$15K ﹤0.01%
450
AXSM icon
1136
Axsome Therapeutics
AXSM
$11.7B
$14K ﹤0.01%
175
RARE icon
1137
Ultragenyx Pharmaceutical
RARE
$2.46B
$14K ﹤0.01%
304
-32
-10% -$1.51K
AHT
1138
Ashford Hospitality Trust
AHT
$20.8M
$13K ﹤0.01%
920
CRNX icon
1139
Crinetics Pharmaceuticals
CRNX
$8.88B
$13K ﹤0.01%
273
FOLD
1140
DELISTED
Amicus Therapeutics
FOLD
$13K ﹤0.01%
1,130
FTRE icon
1141
Fortrea Holdings
FTRE
$1.93B
$13K ﹤0.01%
328
-35
-10% -$1.21K
ACAD icon
1142
Acadia Pharmaceuticals
ACAD
$4.51B
$12K ﹤0.01%
651
ACLX
1143
DELISTED
Arcellx
ACLX
$12K ﹤0.01%
176
ARWR icon
1144
Arrowhead Research
ARWR
$12.1B
$12K ﹤0.01%
426
BMO icon
1145
Bank of Montreal
BMO
$123B
$12K ﹤0.01%
120
IDYA icon
1146
IDEAYA Biosciences
IDYA
$3.43B
$12K ﹤0.01%
264
SWTX
1147
DELISTED
SpringWorks Therapeutics
SWTX
$12K ﹤0.01%
251
DNLI icon
1148
Denali Therapeutics
DNLI
$3.79B
$11K ﹤0.01%
546
SMMT icon
1149
Summit Therapeutics
SMMT
$10.2B
$11K ﹤0.01%
2,728
XENE icon
1150
Xenon Pharmaceuticals
XENE
$6.1B
$11K ﹤0.01%
252

Similar funds

Daiwa Securities Group's Q1 2024 Portfolio in Review

As of Q1 2024, Daiwa Securities Group held 1,375 positions worth $17.7B, up 10% from $16.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group deployed $829M of net new capital in Q1 2024, opening 60 new positions and adding to 737 existing holdings. Its largest new stake was American Healthcare REIT: 241,461 shares worth $3.56M.

By sector, the portfolio is most concentrated in Real Estate at 46% of assets, down from 52% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Mid-America Apartment Communities, an estimated $122M trimmed.

  • Daiwa Securities Group's largest Q1 2024 buy was American Healthcare REIT: 241,461 shares worth $3.56M.
  • Daiwa Securities Group added most to Equinix in Q1 2024, an estimated $115M increase.
  • Daiwa Securities Group's biggest Q1 2024 reduction was Mid-America Apartment Communities, cutting an estimated $122M.
  • Daiwa Securities Group fully exited SPIRIT REALTY CAPITAL, INC. in Q1 2024, selling an estimated $70.5M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $17.7B portfolio in Q1 2024.
  • Daiwa Securities Group opened 60 new positions and closed 62 in Q1 2024.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $17.7B.

Based on Daiwa Securities Group's 13F filing for Q1 2024, filed 2 May 2024.